MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Biotech ETFs: 3 Questions For IShares Investing Expert

TedTed
in The Bullpen
FYI: ETF investors in biotechnology stocks may be rattled by the nose-dive of the first heavyweight out of the earnings gate. IShares Nasdaq Biotechnology (NASDAQ:IBB), the $10 billion biotech exchange traded fund, has lost 0.8% in the past three trading sessions as Illumina (NASDAQ:ILMN) stumbled.
Regards,
Ted
http://license.icopyright.net/user/viewFreeUse.act?fuid=MjAwMjc0ODM=

Enlarged Graphic:
http://news.investors.com/photopopup.aspx?path=WEBetf072315.gif&docId=763009&xmpSource=&width=1000&height=691&caption=&id=763016
Sign In or Register to comment.